Citations

Mayo Clinic

Clear

45 citation(s) found for "Goldman, Jill".

[P1–317]: QUALITY OF LIFE AMONG SUBJECTS AND INFORMANTS IN FAMILIAL FRONTOTEMPORAL DEMENTIA: PRELIMINARY DATA IN THE LEFFTDS COHORT
Calvert, Kendrick J., Rosen, Howard J. , Boxer, Adam L. , Dheel, Christina, Fields, Julie A. , Gavrilova, Ralitza H. , Ghoshal, Nupur , Graff‐Radford, Neill R. , Heuer, Hilary W. , Huey, Edward D. , Hughes, Samantha R., Kornak, John , Kraft, Ruth, Kramer, Joel H. , Mackenzie, Ian R. , Miller, Matt R., Rankin, Katherine , Syrjanen, Jeremy A. , Weıntraub, Sandra , Boeve, Bradley F. , Dickerson, Bradford Clark , Goldman, Jill , Grossman, Murray , Hsiung, Ging‐Yuek Robin , Irwin, David J. , Knopman, David S. , Lapid, Maria I. , Miller, Bruce L. , Wszołek, Zbigniew K.

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2017.06.333 Get It

[P1–254]: CHARACTERISTICS AND PROGRESS ON THE INITIAL 209 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOL
Dheel, Christina, Rosen, Howard J. , Boxer, Adam L. , Coppola, Giovanni , Faber, Kelley, Fields, Julie A. , Gavrilova, Ralitza H. , Ghoshal, Nupur , Graff-Radford, N. R., Heuer, Hilary W. , Huey, Edward D. , Karydas, Anna, Kornak, John , Kramer, Joel H. , Mackenzie, Ian R. , Miller, Matt R., Phelps, Creighton H., Rademakers, Rosa , Rankin, Katherine , Shaw, Leslie M. , Sutherland, Margaret , Syrjanen, Jeremy A. , Trojanowski, John Q. , Vetor, Ashley, Weıntraub, Sandra , Boeve, Bradley F. , Dickerson, Bradford Clark , Foroud, Tatiana , Goldman, Jill , Grossman, Murray , Hsiao, John , Hsiung, Ging‐Yuek Robin , Irwin, David J. , Kantarci, Kejal , Knopman, David S. , Kukull, Walter A. , Miller, Bruce L. , Toga, Arthur W. , Wszołek, Zbigniew K.

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2017.06.270 Get It

O5‐03‐01: Longitudinal evaluation of familial frontotemporal dementia subjects (LEFFTDS): Subject characteristics, aims, and methodology
Rosen, Howard J. , Boxer, Adam L. , Dickerson, Brad C., Ghoshal, Nupur , Graff‐Radford, Neill R. , Huey, Edward D. , Kornak, John , Mackenzie, Ian R. , Petrucelli, Leonard , Rademakers, Rosa , Shaw, Leslie M. , Trojanowski, John Q. , Boeve, Bradley F. , Feldman, Howard , Goldman, Jill , Grossman, Murray , Hsiung, Ging‐Yuek Robin , Irwin, David J. , Jack, Clifford R. , Kantarci, Kejal , Knopman, David S. , Miller, Bruce L. , Toga, Arthur W. , Wszołek, Zbigniew K.

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2015.07.457 Get It

An algorithm for genetic testing of frontotemporal lobar degeneration
Goldman, Jill , Rademakers, Rosa , Huey, Edward D. , Boxer, Adam L. , Mayeux, Richard , Miller, Bruce L. , Boeve, Bradley F. , Goldman, Jill S

Neurology | January 31, 2011 | Volume: 76 | Issue: 5 | Pages: 475-483

10.1212/wnl.0b013e31820a0d13 | PMID 21282594 Get It

New Genes, New Dilemmas: FTLD Genetics and Its Implications for Families
Adamson, Jennifer, Karydas, Anna, Hutton, Mike, Goldman, Jill , Miller, Bruce L.

American Journal of Alzheimer's Disease & Other Dementias® | December 31, 2007 | Volume: 22 | Issue: 6 | Pages: 507-515

10.1177/1533317507306662 | PMID 18166610 Get It

After Alzheimer's disease, frontotemporal lobar degeneration (FTLD) is the second leading cause of dementia in persons less than 65 years of age. Up to 40% of FTLD cases have a positive family history. Research on these families has led to the discovery of four disease-causing genes: microtubule-associated protein tau ( MAPT), progranulin ( PGRN), valosin-containing protein ( VCP), and charged multivesicular body protein 2B ( CHMP2B). MAPT and PGRN are responsible for the largest number of familial cases. Each of these genes differs by disease mechanism. Moreover mutations in both genes are associated with significant interfamilial and intrafamilial phenotypic variation. Genetic counseling needs to address the differences between the PGRN and MAPT mutations as well as the variation in clinical symptoms. The aims of this article are to describe the genetics of the FTLD spectrum and aid in the genetic counseling of individuals who may carry genetic mutations.